<DOC>
	<DOC>NCT00248963</DOC>
	<brief_summary>To evaluate the contraceptive efficacy of an oral contraceptive containing a combination of LNG 90 mg/EE 20 mg in a continuous-use regimen and to evaluate the safety compared to LNG 100 mg/EE 20 mg for 21 days followed by a 7-day hormone-free interval in a cyclic regimen.</brief_summary>
	<brief_title>Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy women aged 18 to 49 years who are willing to rely upon a combination birth control pill as their only method of contraception. Women must be sexually active and at risk for becoming pregnant. Women must have had regular (21 to 35 day) menstrual cycles for the 3month period preceding study visit 1. High blood pressure Age greater then 34 and smoking more than 15 cigarettes per day. Depression requiring hospitalization or associated with suicidal ideation within the last 3 years.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Oral Contraceptive</keyword>
</DOC>